Bases Neurobiológicas y Psicológicas de los Trastornos Mentales. Trastornos del Neurodesarrollo

Cowan HR; Pratt D; Shah JL; Woods SW; Alameda L; Lepage M; Shankman SA; Addington J; Arango C; Bearden CE; Bouix S; Breitborde NJK; Broome MR; Cadenhead KS; Calkins ME; Castillo-Passi RI; Chen EYH; Choi J; Conus P; Corcoran CM; Cornblatt BA; Diaz-Caneja CM; Ellman LM; Fusar-Poli P; Gaspar PA; Gerber C; Glenthøj LB; Gonçalves C; Horton LE; Hui CLM; Kambeitz J; Kambeitz-Ilankovic L; Kahn RS; Kane JM; Keshavan MS; Kim M; Kim SW; Koutsouleris N; Kwon JS; Langbein K; Mamah D; Mathalon DH; McGorry PD; Nelson B; Nordentoft M; Pasternak O; Pearlson GD; Perez J; Perkins DO; Powers AR; Rogers J; Sabb FW; Schiffman J; Shenton ME; Silverstein SM; Smesny S; Stone WS; Strauss GP; Thompson JL; Upthegrove R; Verma S; Wang J; Wolf DH; Yung A; Zhang T; Crawford C; Yassin W; Kelly S; Coleman M; Jacobs G; Lewandowski KE; Penzel N; Baker J; Cecci G; Allott K; Buccilli K; Tod S; Addamo L; Xu L; Mittal VA.

Premorbid adjustment problems, negative symptoms, and cognitive impairment in a large international sample at clinical high risk for psychosis: Findings from the Accelerating Medicines Partnership-Schizophrenia.

SCHIZOPHRENIA BULLETIN. ; : [doi:10.1093/schbul/sbaf197]